Contrary to expectations, the deletion of EZH2 and SUZ12 in both mouse and human GR3 MB via TALEN and CRISPR-Cas9 gene editing is able to accelerate the tumor progression, suggesting a tumor suppressor activity of the protein complex in the tumor (Vo et al., 2017). This evidence concerns the gene EZH2 and neoplasm.